What is Cumberland Pharmaceuticals Inc.'s (CPIX) StockRank?

MoatMap's StockRank for Cumberland Pharmaceuticals Inc. (CPIX) is 38/100, with a Hold signal. This is a composite score combining Quality (43), Value (24), and Momentum (64) factor ranks across MoatMap's universe of 25,000+ stocks.

Does Cumberland Pharmaceuticals Inc. have an economic moat?

Cumberland Pharmaceuticals Inc. (CPIX) has a Quality factor score of 43/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Cumberland Pharmaceuticals Inc. a buy, hold, or sell?

MoatMap's current signal for Cumberland Pharmaceuticals Inc. (CPIX) is Hold, based on a StockRank of 38/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.

What sector is Cumberland Pharmaceuticals Inc. in?

Cumberland Pharmaceuticals Inc. (CPIX) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (United States).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

CPIX

HoldHot Air

Cumberland Pharmaceuticals Inc. · Healthcare · United States · $127M · Avg Vol: $557K/d

StockRank

Get insider-trade alerts

P/E (TTM)

—

ROE

-14.4%

D/E

0.3x

Dividend %

—

COMPANY DESCRIPTION

Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription products for hospital acute care and gastroenterology. The company's competitive moat is its established commercial infrastructure and a portfolio of proprietary, FDA-approved niche drugs. Cumberland operates as a focused specialty drug manufacturer with a targeted sales force in the United States.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR	TTM
Revenue	42.0M	39.6M	37.9M	44.5M	2.0%	44.3M
EPS	-0.38	-0.44	-0.46	-0.19	—	-0.22
Shares	14.4M	14.1M	14.0M	15.0M	+4.1%	15.0M
Debt	21.0M	18.4M	20.6M	10.2M	-21.4%	4.7M
Equity	36.3M	29.6M	22.9M	24.9M	-11.8%	—
Op CF	8.5M	6.1M	-0.6M	4.9M	-16.4%	0.7M
Inv CF	-13.7M	-0.1M	57.8K	-4.7M	—	—
Fin CF	-2.1M	-7.4M	0.2M	-6.7M	—	—

Loading 1Y...

PRICE (1Y)-5.6%

SMA 50SMA 200

$6.29

RSI (14)

36.0

52W High

$9.28

From 52W High

0.7%

SCORE BREAKDOWN

Quality

ROIC

-23.1%28.0

ROE

-14.4%32.4

GP/Assets

49.0%86.0

Op. Margin

-1898.7%5.4

FCF/Assets

-1.5%41.5

Piotroski

668.8

Int. Cover

-30.0x15.1

D/E Ratio

0.28x43.3

Current Ratio

0.96x10.1

Value

P/E (TTM)

—N/A

EV/EBITDA

92.7x5.1

P/FCF

—N/A

P/B

5.8x23.6

P/S

2.3x64.2

Div Yield

—N/A

Momentum

52W High %

68%46.4

RS 6M

144%98.7

SMA 50/200

1.63x99.2

EPS Rev 4W

0.0%34.5

EPS Rev 12W

0.0%41.6

EPS Improve

+164%84.0

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$127M

P/E (Forward)

48.5x

Gross Margin

85.0%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of CPIX are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
CPIX	Cumberland Pharmaceuticals Inc.(you)	$127M	38	Hold
JUSH.CN	Jushi Holdings Inc.	$110M	43	Hold
GRIN.CN	Grown Rogue International Inc.	$111M	46	Hold
SIGA	SIGA Technologies, Inc.	$220M	30	Sell
ORGO	Organogenesis Holdings Inc.	$224M	29	Sell
CL.CN	Cresco Labs Inc.	$291M	43	Hold
DERM	Journey Medical Corporation	$211M	24	Sell
SCYX	SCYNEXIS, Inc.	$54M	31	Sell
TKNO	Alpha Teknova, Inc.	$382M	44	Hold
LFCR	Lifecore Biomedical, Inc.	$172M	16	Strong Sell

Peer medians: ROE -30.8% · P/E 27.0x · Gross margin 58.1%

Cumberland Pharmaceuticals Inc. (CPIX): Stock Score Summary

Cumberland Pharmaceuticals Inc. (CPIX) has a MoatMap StockRank of 38/100 based on Quality (43/100), Value (24/100), and Momentum (64/100) factor scores. The current signal is HOLD.

Key Financial Metrics

Price	$6.29
Market Cap	$127M
P/E (Forward)	48.50
Price/Book	5.83
Return on Equity	-14.4%
Return on Invested Capital	-23.1%
Debt/Equity	0.28x
Gross Margin	85.0%
Operating Margin	-1898.7%
Revenue Growth	-56.3%
Free Cash Flow	$-1M

Cumberland Pharmaceuticals Inc. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Cumberland Pharmaceuticals Inc.’s (CPIX) StockRank?: MoatMap’s StockRank for Cumberland Pharmaceuticals Inc. (CPIX) is 38/100, with a Hold signal. It is a composite of Quality (43), Value (24), and Momentum (64) factor ranks across MoatMap’s universe of 25,000+ stocks.
Does Cumberland Pharmaceuticals Inc. have an economic moat?: Cumberland Pharmaceuticals Inc. (CPIX) has a Quality factor score of 43/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Cumberland Pharmaceuticals Inc. a buy, hold, or sell?: MoatMap’s current signal for Cumberland Pharmaceuticals Inc. (CPIX) is Hold, based on a StockRank of 38/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Cumberland Pharmaceuticals Inc. in?: Cumberland Pharmaceuticals Inc. (CPIX) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (United States).